Compare GRFS & GBCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GRFS | GBCI |
|---|---|---|
| Founded | 1940 | 1955 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.9B |
| IPO Year | 2006 | N/A |
| Metric | GRFS | GBCI |
|---|---|---|
| Price | $9.02 | $45.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $10.15 | ★ $53.60 |
| AVG Volume (30 Days) | 551.2K | ★ 875.1K |
| Earning Date | 01-01-0001 | 01-22-2026 |
| Dividend Yield | 1.58% | ★ 2.88% |
| EPS Growth | N/A | ★ 26.70 |
| EPS | 0.64 | ★ 2.05 |
| Revenue | ★ $8,821,017,248.00 | $900,148,000.00 |
| Revenue This Year | $5.36 | $13.47 |
| Revenue Next Year | $5.15 | $27.72 |
| P/E Ratio | ★ $17.99 | $22.33 |
| Revenue Growth | 7.31 | ★ 15.35 |
| 52 Week Low | $6.19 | $36.76 |
| 52 Week High | $11.14 | $52.81 |
| Indicator | GRFS | GBCI |
|---|---|---|
| Relative Strength Index (RSI) | 53.16 | 64.29 |
| Support Level | $8.69 | $44.66 |
| Resistance Level | $9.22 | $46.48 |
| Average True Range (ATR) | 0.18 | 1.02 |
| MACD | 0.03 | 0.27 |
| Stochastic Oscillator | 64.15 | 84.38 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.